PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Ketamine
Presentation Product Chemical substance Chapter Items dispensed
Ketamine 500mg/10ml solution for injection vials
1501010F0AAABAB
Ketamine (Anaesthesia) Ketamine Anaesthesia 35
Ketamine 200mg/20ml solution for injection vials
1501010F0AAAAAA
Ketamine (Anaesthesia) Ketamine Anaesthesia 16
Ketamine 50mg/5ml solution for injection ampoules
1501010F0AAAEAE
Ketamine (Anaesthesia) Ketamine Anaesthesia 2
Ketalar 1g/10ml solution for injection vials
1501010F0BBADAD
Ketalar Ketamine Anaesthesia No data available
Ketalar 200mg/20ml solution for injection vials
1501010F0BBACAA
Ketalar Ketamine Anaesthesia No data available
Ketalar 500mg/10ml solution for injection vials
1501010F0BBAAAB
Ketalar Ketamine Anaesthesia No data available
Ketamin 10 Curamed 50mg/5ml solution for injection ampoules
1501010F0BCAAAE
Ketamin Ketamine Anaesthesia No data available
Ketamin 100mg/2ml solution for injection ampoules
1501010F0BCABAF
Ketamin Ketamine Anaesthesia No data available
Ketamine 100mg/2ml solution for injection ampoules
1501010F0AAAFAF
Ketamine (Anaesthesia) Ketamine Anaesthesia No data available
Ketamine 1g/10ml solution for injection vials
1501010F0AAADAD
Ketamine (Anaesthesia) Ketamine Anaesthesia No data available
Ketamine 25mg/5ml solution for injection ampoules
1501010F0AAAGAG
Ketamine (Anaesthesia) Ketamine Anaesthesia No data available
Ketamine 50mg/2ml solution for injection ampoules
1501010F0AAAHAH
Ketamine (Anaesthesia) Ketamine Anaesthesia No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.